Changrong Wu

Publications by Year

Research Areas

Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations, Liver Disease Diagnosis and Treatment, Pulmonary Hypertension Research and Treatments

Most-Cited Works

• → Screening of esophageal and gastric cancer by occult blood bead detector(1993)24 cited
• → Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study(2023)9 cited
• [Analysis of the therapeutic effect of esophagectomy with extended 2-field lymph node dissection for esophageal carcinoma].(2009)
• [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].(2007)
• [Right para-tracheal triangle lymphadenectomy for esophageal carcinoma].(2003)
• → Diagnosis and surgical treatment of 103 patients with early esophageal cancer and cardiac cancer of stomach(1994)1 cited
• → Tele‐rehabilitation in COVID‐19 survivors (TERCOV): An investigator‐initiated, prospective, multi‐center, real‐world study(2024)1 cited
• → MRI-Derived Variables Combined with Machine Learning for Pulmonary Hypertension Risk Prediction: A Retrospective Analysis(2025)
• investigation and analysis of blood glucose,blood lipid abnormalities in the part of professional status and risk factors in Xiamen(2012)